Publication | Closed Access

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril

HypertensionCardiovascular DiseaseAntihypertensive TherapyPharmacologyCardiovascular PharmacologyPharmacotherapyEssential HypertensionMedicineBlood PressureAngiotensin-converting Enzyme Inhibitor